Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V36455 | H-Gly-Pro-Arg-Pro-Pro-Glu-Arg-His-Gln-Ser-NH2 | 149836-35-1 | H-Gly-Pro-Arg-Pro-Pro-Glu-Arg-His-Gln-Ser-NH2 is a peptide compound. |
![]() |
V35430 | H-Gly-Pro-Arg-Pro-Pro-NH2 | 126047-84-5 | H-Gly-Pro-Arg-Pro-Pro-NH2 is a peptide compound. |
![]() |
V35431 | H-Gly-Pro-Gly-Gly-OH | 13054-03-0 | H-Gly-Pro-Gly-Gly-OH is a peptide compound. |
![]() |
V35432 | H-Gly-Pro-Gly-NH2·HCl | 141497-12-3 | H-Gly-Pro-Gly-NH2 is a tripeptide that can inhibit HIV-1 replication. |
![]() |
V35433 | H-Gly-Pro-Pro-OH | 13100-15-7 | H-Gly-Pro-Pro-OH is a peptide compound. |
![]() |
V35434 | H-Gly-Trp-Gly-OH | 23067-32-5 | H-Gly-Trp-Gly-OH is a polypeptide. |
![]() |
V35288 | H-Gly-Trp-OH | 2390-74-1 | H-Gly-Trp-OH is a peptide compound. |
![]() |
V35435 | H-Gly-Tyr-NH2 | 15761-60-1 | H-Gly-Tyr-NH2 is a peptide compound. |
![]() |
V35436 | H-Gly-β-Ala-Gly-OH | 16422-05-2 | Glycylalanylglycine is a bioactive peptide discovered by peptide screening. |
![]() |
V35437 | H-Gly-β-Ala-OH | 3695-73-6 | Gly-Ala is a glycine analogue. |
![]() |
V35438 | H-Gly-γ-Abu-OH | 19461-37-1 | H-Gly-γ-Abu-OH is a peptide compound. |
![]() |
V36290 | H-His(Trt)-2-Chlorotrityl Resin | H-Ile-2-Chlorotrityl Resin is a peptide compound. | |
![]() |
V36136 | H-His(Trt)-OMe.HCl | 62715-28-0 | H-His(Trt)-OMe. |
![]() |
V35439 | H-His-Asp-OH | 41658-60-0 | H-His-Asp-OH is a dipeptide. |
![]() |
V35440 | H-His-Gly-OH | 2578-58-7 | (S)-2-(2-Amino-3-(1H-imidazol-4-yl)propanamido)acetic acid is a glycine analogue. |
![]() |
V35441 | H-HIS-HIS-GLY-VAL-VAL-GLU-VAL-ASP-ALA-ALA-VAL-THR-PRO-GLU-GLU-ARG-HIS-LEU-SER-LYS-OH | 158561-91-2 | H-HIS-HIS-GLY-VAL-VAL-GLU-VAL-ASP-ALA-ALA-VAL-THR-PRO-GLU-GLU-ARG-HIS-LEU-SER-LYS-OH is a peptide compound. |
![]() |
V34886 | H-His-Leu-Pro-Pro-Pro-Val-His-Leu-Pro-Pro-Pro-Val-OH | 154244-49-2 | H-His-Leu-Pro-Pro-Pro-Val-His-Leu-Pro-Pro-Pro-Val-OH is a peptide compound. |
![]() |
V34885 | H-His-Leu-Pro-Pro-Pro-Val-OH | 121305-29-1 | H-His-Leu-Pro-Pro-Pro-Val-OH is a peptide compound. |
![]() |
V35442 | H-His-Lys-OH·HBr | 151151-29-0 | H-His-Lys-OH·HBr is a peptide compound. |
![]() |
V35443 | H-His-Phe-OH | 16874-81-0 | H-His-Phe-OH is a dipeptide. |